DEF — Defense
Patient access to non-opioid analgesic drug treatments. Biodefense countermeasures fundings.
Lobbyists: STEVEN WOLFE
Government entities lobbied: HOUSE OF REPRESENTATIVES; SENATE
1st Quarter - Report · 2026
- Filing UUID
210702ee-1574-4f22-961e-1d7fd583d04a- Type
Q1— 1st Quarter - Report- Period
- first_quarter
- Year
- 2026
- Posted
- 2026-04-16 20:16:53
- Income (reported)
- $40,000
- Expenses (reported)
- —
- Filing document
- Open on lda.senate.gov
Registrant (lobbying firm)
STRATEGIC MARKETING INNOVATIONS
Federal relations firm
- Contact
- KENNETH WETZEL, JR.
- Phone
- +1 202-467-5459
- Address
- zip:20001, city:Washington, state:DC, street:200 Massachusetts Avenue Suite 510
Client
Clinical-stage biopharmaceutical company
- State
- MA
- Country
- US
- Effective date
- 2025-11-01
Issues lobbied + lobbyists
HCR — Health Issues
Patient access to non-opioid analgesic drug treatments. Biodefense countermeasures fundings.
Lobbyists: STEVEN WOLFE
Government entities lobbied: HOUSE OF REPRESENTATIVES; SENATE